To include your compound in the COVID-19 Resource Center, submit it here.

MLANA-loaded nanoparticle vaccine plus mAbs against PD-1 and OX40 to sensitize melanoma to Imbruvica

DISEASE CATEGORY: Cancer

INDICATION: Melanoma

Immunization with an MLANA-loaded nanoparticle vaccine in combination with mAbs against PD-1 and OX40 could

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE